Get the Stockscreener App
21.51
0.23%
+0.05
Fusion Pharmaceuticals Inc Stock (FUSN) Forecast
The Fusion Pharmaceuticals Inc (FUSN) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $19.09, representing a -11.25% decrease from the current price of $21.51. The highest analyst price target is $21.54, and the lowest is $16.64.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FUSN Price Target
Average 16.41
(-23.69% Downside)
Is Fusion Pharmaceuticals Inc (FUSN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 72.88 | Sell |
| STOCH(9,6) | 61.63 | Neutral |
| STOCHRSI(14) | 13.00 | Buy |
| MACD(12,26) | 0.4219 | Sell |
| ADX(14) | 59.93 | Buy |
| William %R | -30.43 | Neutral |
| CCI(14) | 97.43 | Neutral |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
21.45
Buy
|
21.46
Buy
|
| MA20 |
21.43
Buy
|
21.28
Buy
|
| MA50 |
19.73
Buy
|
19.37
Buy
|
| MA100 |
15.14
Buy
|
15.98
Buy
|
| MA200 |
9.4969
Buy
|
12.00
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, FUSN could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 2 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on FUSN, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 72.88 indicates that FUSN is overbought. This suggests that FUSN price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 61.63 indicates that FUSN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 13 indicates that FUSN is oversold. This suggests that FUSN price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 59.93 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 97.43 indicates that FUSN is still overbought but not to an extreme extent.
Long-term FUSN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Fusion Pharmaceuticals Inc financial reports and earnings history, Fusion Pharmaceuticals Inc (FUSN) stock could reach $19.02 by 2030, $24.01 by 2040 and $37.17 by 2050. See the projected annual prices until 2050 of the Fusion Pharmaceuticals Inc stock below:
- Fusion Pharmaceuticals Inc (FUSN) is expected to reach an average price of $22.38 in 2035, with a high prediction of $22.69 and a low estimate of $21.59. This indicates an $4.02% rise from the last recorded price of $21.51.
- Fusion Pharmaceuticals Inc (FUSN) stock is projected to chart a bullish course in 2040, with an average price target of $23.36, representing an $8.60% surge from its current level. The forecast ranges from a conservative $22.57 to a sky-high $24.01.
- Our analysts predict Fusion Pharmaceuticals Inc (FUSN) to jump 40.87% by 2045, soaring from $29.83 to an average price of $30.30, potentially reaching $30.85. While $29.83 is the low estimate, the potential upside is significant.
- Fusion Pharmaceuticals Inc (FUSN) stock is expected to climb by 2050, reaching an average of $37.06, a $72.30% jump from its current level. However, a wide range of estimates exists, with high and low targets of $37.17 and $35.77, respectively, highlighting the market's uncertainty.
Fusion Pharmaceuticals Inc Stock (FUSN) Year by Year Forecast
Fusion Pharmaceuticals Inc Stock (FUSN) Price Forecast for 2024
Our forecast for FUSN stock price in 2024 now indicates an average price target of $15.51 with a high forecast of $23.42 and a low forecast of $7.59. The average prediction reflects an decrease of -27.92% from the last recorded price of $21.51.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $17.81 | $16.64 | $21.54 | -17.22% |
| July, 2024 | $16.75 | $16.73 | $18.18 | -22.13% |
| August, 2024 | $16.52 | $16.21 | $17.38 | -23.20% |
| September, 2024 | $16.89 | $16.01 | $17.64 | -21.48% |
| October, 2024 | $16.94 | $16.69 | $18.27 | -21.27% |
| November, 2024 | $16.62 | $15.96 | $18.25 | -22.75% |
| December, 2024 | $17.10 | $15.80 | $17.40 | -20.52% |
Fusion Pharmaceuticals Inc Stock (FUSN) Price Forecast for 2025
Fusion Pharmaceuticals Inc Stock (FUSN) is expected to reach an average price of $13.62 in 2025, with a high prediction of $17.89 and a low estimate of $9.3415. This indicates an -36.70% fall from the last recorded price of $21.51.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $16.65 | $15.11 | $17.89 | -22.59% |
| February, 2025 | $16.48 | $15.37 | $16.84 | -23.38% |
| March, 2025 | $14.16 | $13.95 | $17.11 | -34.17% |
| April, 2025 | $12.85 | $12.75 | $14.41 | -40.26% |
| May, 2025 | $12.85 | $11.29 | $13.48 | -40.28% |
| June, 2025 | $12.87 | $12.56 | $15.10 | -40.19% |
| July, 2025 | $12.86 | $12.49 | $13.94 | -40.21% |
| August, 2025 | $14.09 | $12.70 | $14.26 | -34.49% |
| September, 2025 | $13.14 | $13.11 | $14.18 | -38.91% |
| October, 2025 | $12.04 | $11.87 | $13.25 | -44.04% |
| November, 2025 | $10.83 | $10.83 | $12.26 | -49.67% |
| December, 2025 | $9.9516 | $9.3415 | $11.12 | -53.74% |
Fusion Pharmaceuticals Inc Stock (FUSN) Price Forecast for 2026
The predicted value for Fusion Pharmaceuticals Inc (FUSN) in 2026 is set at an average of $10.32. Estimates vary from a peak of $13.61 to a trough of $7.0373, indicating an -52.01% surge from the present price of $21.51.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $11.47 | $8.9516 | $11.47 | -46.67% |
| February, 2026 | $12.81 | $10.99 | $13.61 | -40.44% |
| March, 2026 | $12.44 | $12.12 | $13.55 | -42.16% |
| April, 2026 | $12.71 | $11.74 | $12.81 | -40.93% |
| May, 2026 | $10.76 | $10.34 | $12.89 | -49.97% |
| June, 2026 | $8.846 | $8.682 | $11.17 | -58.87% |
| July, 2026 | $8.2521 | $8.2521 | $9.0521 | -61.64% |
| August, 2026 | $7.5422 | $7.4222 | $8.567 | -64.94% |
| September, 2026 | $7.1873 | $7.0373 | $7.5822 | -66.59% |
| October, 2026 | $7.4988 | $7.0673 | $7.5374 | -65.14% |
| November, 2026 | $8.0974 | $7.3524 | $8.7774 | -62.36% |
| December, 2026 | $7.5625 | $7.3075 | $8.3425 | -64.84% |
Fusion Pharmaceuticals Inc Stock (FUSN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Fusion Pharmaceuticals Inc (FUSN) is $9.0129, with a high forecast of $10.92 and a low forecast of $7.1026. This indicates an -58.10% decrease from the last price of $21.51.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.2676 | $7.1026 | $7.7276 | -66.21% |
| February, 2027 | $7.8627 | $7.1964 | $8.0227 | -63.45% |
| March, 2027 | $8.5578 | $7.6577 | $9.2573 | -60.21% |
| April, 2027 | $8.6378 | $8.1128 | $8.8328 | -59.84% |
| May, 2027 | $10.01 | $8.4729 | $10.42 | -53.47% |
| June, 2027 | $8.943 | $8.878 | $10.07 | -58.42% |
| July, 2027 | $9.4631 | $8.493 | $9.8579 | -56.01% |
| August, 2027 | $10.38 | $9.3682 | $10.38 | -51.73% |
| September, 2027 | $9.9782 | $9.4587 | $10.92 | -53.61% |
| October, 2027 | $8.6483 | $8.4884 | $10.05 | -59.79% |
| November, 2027 | $8.0984 | $8.0784 | $8.8133 | -62.35% |
| December, 2027 | $7.9435 | $7.6835 | $8.8034 | -63.07% |
Fusion Pharmaceuticals Inc Stock (FUSN) Price Forecast for 2028
In 2028, Fusion Pharmaceuticals Inc (FUSN) is projected to reach an average price of $17.77, with a high projection of $27.84 and a low estimate of $7.7035. This indicates an -17.38% fall from the last price of $21.51.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $9.5236 | $7.7035 | $9.5636 | -55.72% |
| February, 2028 | $9.9836 | $9.1586 | $10.16 | -53.59% |
| March, 2028 | $10.79 | $9.1986 | $11.14 | -49.84% |
| April, 2028 | $15.07 | $10.23 | $15.89 | -29.95% |
| May, 2028 | $17.10 | $13.05 | $17.72 | -20.48% |
| June, 2028 | $17.64 | $15.61 | $19.49 | -17.97% |
| July, 2028 | $15.51 | $14.61 | $18.62 | -27.88% |
| August, 2028 | $26.81 | $15.33 | $27.09 | +24.64% |
| September, 2028 | $25.84 | $25.34 | $27.84 | +20.13% |
| October, 2028 | $24.73 | $23.86 | $27.35 | +14.97% |
| November, 2028 | $22.28 | $21.09 | $25.43 | +3.58% |
| December, 2028 | $21.42 | $21.21 | $22.24 | -0.42% |
Fusion Pharmaceuticals Inc Stock (FUSN) Price Forecast for 2029
The 2029 price forecast for Fusion Pharmaceuticals Inc Stock (FUSN) is $19.39 on average, with a high prediction of $22.80 and a low estimate of $15.97. This represents an -9.88% decrease from the previous price of $21.51.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $21.23 | $20.52 | $21.83 | -1.30% |
| February, 2029 | $21.83 | $20.92 | $22.80 | +1.49% |
| March, 2029 | $22.13 | $21.29 | $22.77 | +2.89% |
| April, 2029 | $21.44 | $20.52 | $22.80 | -0.32% |
| May, 2029 | $20.49 | $19.70 | $22.48 | -4.74% |
| June, 2029 | $20.91 | $20.20 | $21.86 | -2.78% |
| July, 2029 | $19.39 | $19.37 | $21.74 | -9.85% |
| August, 2029 | $17.81 | $17.41 | $20.43 | -17.19% |
| September, 2029 | $17.55 | $15.97 | $18.63 | -18.40% |
| October, 2029 | $17.47 | $17.25 | $19.80 | -18.77% |
| November, 2029 | $17.54 | $17.37 | $17.75 | -18.45% |
| December, 2029 | $17.73 | $17.22 | $18.67 | -17.56% |
Fusion Pharmaceuticals Inc Stock (FUSN) Price Forecast for 2030
Fusion Pharmaceuticals Inc Stock (FUSN) is expected to reach an average price of $15.84 in 2030, with a high forecast of $19.02 and a low forecast of $12.65. This signifies an -26.37% decrease from the last price of $21.51.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $18.65 | $17.45 | $19.02 | -13.28% |
| February, 2030 | $17.33 | $17.33 | $18.79 | -19.42% |
| March, 2030 | $16.62 | $16.51 | $17.62 | -22.74% |
| April, 2030 | $15.79 | $15.35 | $16.92 | -26.58% |
| May, 2030 | $14.70 | $14.18 | $15.95 | -31.68% |
| June, 2030 | $17.31 | $13.81 | $18.48 | -19.51% |
| July, 2030 | $17.65 | $16.77 | $18.45 | -17.95% |
| August, 2030 | $17.14 | $16.66 | $17.99 | -20.30% |
| September, 2030 | $17.74 | $16.70 | $17.80 | -17.53% |
| October, 2030 | $14.68 | $14.68 | $17.83 | -31.73% |
| November, 2030 | $13.66 | $13.43 | $14.57 | -36.48% |
| December, 2030 | $12.76 | $12.65 | $13.92 | -40.66% |
0.77%
1.20%
Cap:
|
Volume (24h):